




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Invasive Cardiovascular Angiography and Intervention</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=2d1edb86-1b6a-4771-8577-42769c4272ef</link>
        <description>Clinical Topic Feed: Invasive Cardiovascular Angiography and Intervention</description>
        <language>en</language>

        

                <item>
                    <title>ACC, STS and SCAI Issue Joint Statement on TAVR National Coverage Determination</title>
<link>/Latest-in-Cardiology/Articles/2026/09/11/18/54/ACC-STS-and-SCAI-Issue-Joint-Statement-on-TAVR-National-Coverage-Determination</link>                    <description>The American College of Cardiology (ACC), Society of Thoracic Surgeons (STS) and Society for Cardiovascular Angiography &amp;amp; Interventions (SCAI) released the following joint statement on the transcatheter aortic valve replacement (TAVR) national coverage determination finalized by the Centers for Medicare and Medicaid Services (CMS).</description>
                    <pubdate>1789153980000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ALL-RISE: Angiography-Derived Physiology Simplifies PCI Without Compromising Outcomes</title>
<link>/Latest-in-Cardiology/Articles/2026/09/08/14/17/ALL-RISE</link>                    <description>The ALL-RISE (Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment) trial results demonstrated that, among patients with intermediate coronary stenoses undergoing invasive angiography, an angiography-derived fractional flow reserve (FFRangio [Medtronic]) strategy was noninferior to pressure wire&#226;€“based physiological assessment for death, myocardial infarction, or unplanned clinically indicated revascularization at 1 year.</description>
                    <pubdate>1789044900000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>HI-PEITHO and the Evolution of Reperfusion Strategies in Pulmonary Embolism</title>
<link>/Latest-in-Cardiology/Articles/2026/09/08/14/17/HI-PEITHO-and-the-Evolution-of-Reperfusion-Strategies-in-Pulmonary-Embolism</link>                    <description>Management of intermediate-risk pulmonary embolism (PE) remains one of the most challenging areas in venous thromboembolism care. These patients are hemodynamically stable but have right ventricular (RV) dysfunction and myocardial injury, placing them at increased risk of clinical deterioration.</description>
                    <pubdate>1788962340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Top Trials from ESC 26</title>
<link>/Latest-in-Cardiology/Articles/2026/09/09/13/47/eagles-eye-view-09sep2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at some of the important trials presented at this year&#226;€™s European Society of Cardiology (ESC) Congress.</description>
                    <pubdate>1788961680000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Featured Jobs For September 2026</title>
<link>/Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs</link>                    <description>Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!</description>
                    <pubdate>1788305160000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC in a Flash | Persistent Excess CV Mortality in Black Americans; TAVR at 10 Years; More</title>
<link>/Latest-in-Cardiology/Articles/2026/09/01/01/JACC-in-a-Flash</link>                    <description>Featured topics and Editors&#39; Picks from all of ACC&#39;s JACC Journals.</description>
                    <pubdate>1788264600000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Journal Wrap | Lifestyle Intervention Effective in Prediabetes; Aficamten Tops Metoprolol For Exercise in oHCM; More</title>
<link>/Latest-in-Cardiology/Articles/2026/09/01/01/Journal-Wrap</link>                    <description>The hottest research from various peer-reviewed journals &#226;€“ handpicked weekly by the ACC.</description>
                    <pubdate>1788264540000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Analyses Examine mAFP Costs, Compare Mortality With PCI vs. CABG</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/mon-9am-jacc-mortality-esc-2026</link>                    <description>Two studies presented at ESC Congress 2026, and published in JACC offer new insights into the costs and long-term outcomes of cardiovascular therapies, with one analysis examining hospital costs associated with microaxial flow pump (mAFP) therapy and another assessing 20-year all-cause mortality after PCI vs. CABG.</description>
                    <pubdate>1788181200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>CorCal Outcomes, EVAOLD, ISOLEDS Inform CV Risk Prediction, Post-MI Treatment and Stenting Strategies</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/mon-730am-corcal-evaold-isoleds-esc-2026</link>                    <description>Cardiovascular prevention, acute care and interventional cardiology converged in a wide-ranging Hot Line Session at ESC Congress 2026 that delivered new evidence on how clinicians assess risk, treat older heart attack patients and guide complex coronary procedures.</description>
                    <pubdate>1788177780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Late-Breaking Science Explores PET Imaging, HELIOS-B, DAPA ACT HF-TIMI 68 Analyses</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/sun-jacc-lbs-esc-2026</link>                    <description>Late-breaking science presented at ESC Congress 2026 and simultaneously published in JACC Journals explore the performance of 124I-evuzamitide PET/MRI in patients with established or suspected cardiac amyloidosis (CA), treatment effect of vutrisiran by baseline tafamidis use, and impact of dapagliflozin on congestion in patients hospitalized for heart failure (HF).</description>
                    <pubdate>1788101460000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>